Docoh
Loading...

GWPRF GW Pharmaceuticals

GRANT
Utility
pH dependent release coated microparticle cannabinoid formulations
2 Nov 21
The present disclosure provides a microparticulate comprising one or more cannabinoids and a pH dependent release polymer.
Jitinder Wilkhu, Alan Silcock
Filed: 12 Oct 20
GRANT
Utility
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
2 Nov 21
The present disclosure provides methods of treating tuberous sclerosis complex comprising administering cannabidiol and everolimus.
Geoffrey Guy, Volker Knappertz, Eduardo Dunayevich, David Critchley
Filed: 1 Mar 21
APP
Utility
Use of Cannabidiol In the Treatment of Epilepsy
28 Oct 21
The present disclosure relates to the use of cannabidiol (CBD) for the reduction of seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE).
Geoffrey GUY, Stephen WRIGHT, Orrin DEVINSKY
Filed: 21 Jul 20
GRANT
Utility
Use of cannabinoids in the treatment of epilepsy
26 Oct 21
The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE).
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 11 Dec 20
GRANT
Utility
Use of cannabinoids in the treatment of epilepsy
26 Oct 21
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 27 Apr 21
GRANT
Utility
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy
19 Oct 21
The present invention relates to the use of 7-hydroxy-cannabidol (7-OH-CBD) and/or 7-hydroxy-cannabidivarin (7-OH-CBDV) in the treatment of epilepsy.
Colin Stott, Nick Jones, Benjamin Whalley, Gary Stephens, Claire Williams
Filed: 3 Oct 19
GRANT
Utility
Use of cannabinoids in the treatment of epilepsy
19 Oct 21
The present invention relates to the use of a therapeutically effective amount of cannabidiolic acid (CBDA) in the treatment of epilepsy.
Colin Stott, Nicholas Jones, Robin Williams, Benjamin Whalley
Filed: 29 Jul 16
APP
Utility
Combination of Cannabinoids In the Treatment of Leukaemia
7 Oct 21
The present invention relates to the use of a combination of two different cannabinoids in the treatment of leukaemia.
Stephen Wright, Wai Liu, Katherine Scott, Angus Dalgleish
Filed: 15 Apr 21
APP
Utility
Use of Cannabidiol In the Treatment of Epilepsy
23 Sep 21
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC).
Geoffrey GUY, Stephen Wright, Elizabeth Thiele
Filed: 7 Jun 21
APP
Utility
Methods of Treating Tuberous Sclerosis Complex with Cannabidiol and Everolimus
2 Sep 21
The present disclosure provides methods of treating tuberous sclerosis complex comprising administering cannabidiol and everolimus.
Geoffrey GUY, Volker KNAPPERTZ, Eduardo DUNAYEVICH, David CRITCHLEY
Filed: 1 Mar 21
GRANT
Utility
Use of cannabinoids in the treatment of epilepsy
24 Aug 21
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 11 Mar 21
APP
Utility
Use of Cannabinoids In the Treatment of Epilepsy
12 Aug 21
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 27 Apr 21
APP
Utility
Pharmaceutical Formulation
22 Jul 21
The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray.
Brian Anthony Whittle
Filed: 1 Oct 20
GRANT
Utility
Use of cannabidiol in the treatment of epilepsy
20 Jul 21
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC).
Geoffrey Guy, Stephen Wright, Elizabeth Thiele
Filed: 12 Jan 21
GRANT
Utility
Use of cannabinoids in the treatment of multiple myeloma
20 Jul 21
The present invention relates to the use of a combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) in the treatment of multiple myeloma.
Colin Stott, Massimo Nabissi
Filed: 31 Jul 17
APP
Utility
Use of Cannabidiolic Acid In the Treatment of Autism Spectrum Disorder and Associated Disorders
8 Jul 21
The present invention relates to the use of cannabidiolic acid (CBDA) in the treatment of autism spectrum disorder (ASD) and ASD-associated disorders, such as Fragile X syndrome (FXS); Rett syndrome (RS); or Angelman syndrome (AS).
Geoffrey GUY, Stephen WRIGHT, James BRODIE, Marie WOOLLEY-ROBERTS, Rafael MALDONADO, Daniela PAROLARO, Livio LUONGO
Filed: 21 Dec 20
APP
Utility
Use of Cannabinoids In the Treatment of Epilepsy
1 Jul 21
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey GUY, Stephen WRIGHT, Orrin DEVINSKY
Filed: 11 Mar 21
APP
Utility
Use of Cannabinoids In the Treatment of Epilepsy
17 Jun 21
The present invention relates to the use of cannabidiol (CBD) in the treatment of patients with childhood-onset epilepsy who are concurrently taking immunosuppressant drugs.
Geoffrey GUY, Volker KNAPPERTZ
Filed: 30 Nov 18
APP
Utility
Use of Cannabinoids In the Treatment of Seizures As Associated with Lennox-gastaut Syndrome
10 Jun 21
The present invention relates to the use of cannabidiol (CBD) in the treatment of patients with Lennox-Gastaut syndrome (LGS) who are deemed to be treatment failures on their existing medication.
Geoffrey GUY, Volker KNAPPERTZ
Filed: 15 Nov 18
APP
Utility
Use of Cannabidiol In the Treatment of Epilepsy
20 May 21
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC).
Geoffrey GUY, Stephen WRIGHT, Elizabeth THIELE
Filed: 12 Jan 21
Patents are sorted by USPTO publication date, most recent first